Therapeutic Adherence in Patients With Chronic Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

220 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-08

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives of the study are:

* The validation of the GMAS questionnaire in patients with chronic disease.
* Measurement of the level of therapeutic adherence in patients with chronic illness.
* Measurement of the level of therapeutic adherence in patients with chronic disease undergoing an experimental trial.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness and Cost-effectiveness of the Initial Medication Adherence Intervention

NCT05026775

Adherence, Medication

UNKNOWN NA

Quality of Life in Patients With Chronic Disease

NCT03925805

Chronic Disease Quality of Life Cardiovascular Diseases +3 more

COMPLETED

Analysis of the Efficiency of a Chronic Disease Self-Management Programme in a Vulnerable Population in Five European Countries

NCT03840447

Chronic Disease

COMPLETED NA

Improving Therapeutic Adherence in Cardiovascular Secondary Prevention.

NCT06510946

Cardiovascular Diseases Chronic Disease Secondary Prevention +1 more

NOT_YET_RECRUITING NA

The Impact of Lifestyle Medicine on the Sense Of Coherence and Biological Age in a Community Sample

NCT06671301

Healthy Volunteers Only Healthy Adults

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The research is multicentre and will be conducted at the Fondazione Policlinico Gemelli IRCCS in Rome as reference centre together with the other participating centres. Patients will be enrolled at the centres involved, either during visits or during their hospital stay.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Validation of questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronically ill;
* Age 18 years or older;
* Willingness to participate in the study;
* Chronic illness diagnosed at least 3 months before the start of the study;
* Reading and signing the informed consent.

Exclusion Criteria

* Reduced command of the Italian language;
* Subjects suffering from severe psychiatric disorders;
* Serious clinical conditions that do not permit completion of the questionnaire;
* Refusal to sign the informed consent to participate in the study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No